Stay up-to-date on the latest news and press invloving CTI's work in COVID-19
CTI’s Clinical Research Center (CTI CRC) is a vaccine-experienced clinical research unit in Cincinnati, OH that has been conducting clinical trials for more than 20 years, and has completed over 900 trials across all phases of development. The team has contributed to multiple vaccine trials, including work in pandemic environments during the H1N1 (swine flu) outbreak, where the team conducted two Phase II trials and enrolled over 100 subjects in ~24 hours, and the H5N1 (bird flu) outbreak, where the Phase I trial went through an FDA audit with no 483s issued to the site. Additionally, the unit has collaborated with large pharmaceutical companies and emerging biopharmaceutical companies as part of trials resulting in vaccine approvals in areas including HPV, influenza, meningococcal group B, shingles and swine flu. The CRC has completed 15 recent vaccine trials with a 92% subject retention rate.
The CTI CRC is part of a larger, global clinical research organization (CRO), which has been specializing in complex programs and critically-ill patient populations for three decades and is currently working on more than 15 COVID-19 programs. CTI's infectious disease experience here and more about our work with COVID-19 initiatives here.
The CTI CRC provides full-service support solutions, including an onsite processing laboratory and data-related services. Investigators are board-certified, and research coordinators are versatile and well trained.
The CRC has updated its processes and procurement in this COVID-19 time, including:
The CTI CRC houses a 30-bed clinical research unit with state-of-the-art equipment. The facility layout lends itself to conducting studies in the COVID-19 environment, offering separate patient units that are ideal for isolating subjects. The CTI CRC is physically adjacent to a college campus, and close to many major hospitals, resulting in the potential for patient referrals, an extensive principal investigator (PI) network, and a large database of both normal healthy volunteers (NHVs) and patient populations. In addition to its permanent staff, CTI CRC has a sizable pool of as-needed personnel including physicians, pharmacists, skilled nurses, emergency medical technicians (EMTs), paramedics, phlebotomists, and a team of experts in clinical pharmacology, pharmacokinetics (PK), and drug metabolism.
The CTI CRC has a dedicated subject recruitment and patient marketing department. Since the onset of the pandemic, the team has significantly accelerated recruiting efforts to prepare for COVID-19 therapeutic and vaccine programs.